Tamoxifen and uterine leiomyoma Patient Reports February 10, 2012

Tamoxifen Side Effects Report #5259642-6
Tamoxifen side effect was reported by a Pharmacist from UNITED STATES on Mar 07, 2007. Female patient, 48 years of age, weighting 180.0 lb, was diagnosed with neoplasm prophylaxis and was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: endometrial hyperplasia, hepatic steatosis, hypertriglyceridaemia, menopause , uterine cyst, uterine leiomyoma, vaginal discharge. Tamoxifen dosage: 20 MG DAILY PO. Patient recovered.

Tamoxifen Side Effects Report #4939566-1
Tamoxifen side effect was reported by a Health Professional from UNITED KINGDOM on Feb 27, 2006. Female patient, 47 years of age, was diagnosed with breast cancer stage i and was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: adenomyosis, cervical polyp, endometrial hyperplasia, endometriosis , uterine leiomyoma. Tamoxifen dosage: unknown. Patient was hospitalized. Patient recovered.

Tamoxifen Side Effects Report #5019406-5
Tamoxifen side effect was reported by a Consumer or non-health professional from BRAZIL on May 29, 2006. Female patient, 56 years of age, weighting 101.4 lb, was diagnosed with breast cancer female, hypertension and was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: uterine leiomyoma, visual field defect. Tamoxifen dosage: unknown. During the same period patient was treated with SELOZOK. Patient recovered.

Tamoxifen Side Effects Report #5266879-9
Tamoxifen side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2002. Female patient, 61 years of age, weighting 145.0 lb, was diagnosed with breast cancer  and was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: endometrial disorder, flushing, uterine leiomyoma, vaginal haemorrhage. Tamoxifen dosage: 10 MG BID PO. Patient recovered.


Tamoxifen Side Effects Report #5876064-5
Tamoxifen side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 26, 2008. Female patient, 56 years of age, was diagnosed with breast cancer  and was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: adenomyosis, cervicitis, uterine leiomyoma. Tamoxifen dosage: 20 MG TIMES PR. 1. DAY. Patient was hospitalized. Patient recovered.

Tamoxifen Side Effects Report #5957290-3
Tamoxifen side effect was reported by a Physician from GERMANY on Oct 31, 2008. Female patient, 54 years of age, weighting 229.3 lb, was diagnosed with breast cancer  and was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: adhesion , endometriosis , ovarian cyst , pelvic mass, polyp, progesterone decreased, salpingitis, uterine leiomyoma. Tamoxifen dosage: 10 MG TIMES PR. 1. DAY. Patient recovered.

Tamoxifen Side Effects Report #5466610-8
Tamoxifen side effect was reported by a Physician from FRANCE on Sept 14, 2007. Female patient, 75 years of age, was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: metrorrhagia, uterine leiomyoma. Tamoxifen dosage: unknown. Patient was hospitalized. Patient recovered.

Tamoxifen Side Effects Report #5581888-8
Tamoxifen side effect was reported by a Physician from FRANCE on Dec 27, 2007. Female patient, 75 years of age, was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: metrorrhagia, uterine leiomyoma. Tamoxifen dosage: unknown. Patient was hospitalized. Patient recovered.

Tamoxifen Side Effects Report #5270090-5
Tamoxifen side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 30, 2005. Female patient, 70 years of age, was treated with Tamoxifen. After drug was administered, patient experienced the following side effects: endometrial hypertrophy, uterine leiomyoma. Tamoxifen dosage: unknown. Patient recovered.